New Agents in the Treatment of Small-Cell Lung Cancer: Focus on Gemcitabine
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference73 articles.
1. Lung Cancer. Time to move on from Chemotherapy;Carney;N Engl J Med,2002
2. Cancer Statistics 2002;Jemal;CA Cancer J Clin,2002
3. Management of Small Cell Lung Cancer;Johnson;Clin Chest Med,2002
4. Epidemiology of lung cancer;Smith;Radiol Clin North Am,2000
5. New drugs for chemotherapy-naïve patients with extensive disease small cell lung cancer;Ettinger;Semin Oncol,2001
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Effect of PEGylation on Drugs’ Pharmacokinetic Parameters; from Absorption to Excretion;Current Drug Delivery;2024-08
2. Comparative pharmacokinetic study of PEGylated gemcitabine and gemcitabine in rats by LC-MS/MS coupled with pre-column derivatization and MSALL technique;Talanta;2020-01
3. Long Non-Coding RNAs as New Master Regulators of Resistance to Systemic Treatments in Breast Cancer;International Journal of Molecular Sciences;2018-09-11
4. Lung Cancer;Serous Effusions;2018
5. Small-Cell Lung Cancer: An Update on Targeted Therapies;Advances in Experimental Medicine and Biology;2012-11-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3